The impact of comorbidity on the management of pathological gambling

CNS Spectrums

Volumn 10, Issue 8, 2005, Pages 619-621

  Dell'Osso, Bernardo ^a   Hollander, Eric ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LITHIUM;

ADULT; ARTICLE; CASE REPORT; COMORBIDITY; CYCLOTHYMIA; DISEASE COURSE; FEMALE; HUMAN; MOOD DISORDER; OBSESSIVE COMPULSIVE DISORDER; PATHOLOGICAL GAMBLING; PRIORITY JOURNAL; PSYCHOPHARMACOTHERAPY; PSYCHOTHERAPY; SIDE EFFECT; SUBSTANCE ABUSE; TREATMENT OUTCOME;

EID: 24144485838     PISSN: 10928529     EISSN: None     Source Type: Journal    
DOI: 10.1017/S109285290001957X     Document Type: Article

References (20)

1. Diagnostic and Statistical Manual of Mental Disorders. 4th ed. text rev. Washington, DC: American Psychiatric Association; 2000.
2. Shaffer HJ, Hall MN, Vamler Bilt J. Estimating the prevalence of disordered gambling behavior in the United States and Canada: a research synthesis. Am J Public Health. 1999;89:1369-1376.
3. Hollander E, Buchalter AJ, DeCaria CM. Pathological gambling. Psychiatr Clin North Am. 2000;23:629-642.
4. National Research Council. Pathological Gambling: A Critical Review. Washington, DC: National Academy Press; 1999.
5. Hollander E, Frenkel M, Decaria C, Trungold S, Stein HJ. Treatment of pathological gambling with clomipramine. Am J Psychiatry. 1992;149:710-711.
6. Hollander E, DeCaria CM, Mari E, et al. Short-tenu single-blind fluvoxamine treatment of pathological gambling. Am J Psychiatry. 1998;155:1731-1783.
7. Hollander E, DeCaria CM, Finkell JN, Begaz T, Wong CM, Cartwright C. A randomized double-blind fluvoxamine/placebo crossover trial in pathological gambling. Biol Psychiatry. 2000;47:813-817.
8. Zimmerman M, Breen RB, Posternak MA. An open-label study of citalopram in the treatment of pathological gambling. J Clin Psychiatry. 2002;63:44-48.
9. Kim SW, Grant JE, Adson DE, et al. A double-blind placebo-controlled study of the efficacy and safety of paroxetine in the treatment of pathological gambling. J Clin Psychiatry. 2002;63:501-507.
10. Blanco C, Petkova E, Ibanez A, Saiz-Ruiz J. A pilot placebo-controlled study of fluvoxamine for pathological gambling. Ann Clin Psychiatry. 2002;14:9-15.
11. DeCaria CM, Hollander E, Begaz T, et al. Reliability and validity of a pathological gambling modification of the Yale-Brown Ohsessive-Compulsive Scale (PGYBOCS): preliminary findings. In: Proceedings of the 12th National Conference on Problem Gambling. Washington, DC: National Council on Problem Gambling; 1998.
12. Guy W, ed. ECDEU Assessment Manual of Psychopharmacology. Washington, DC: US Department of Health, Education, and Welfare; 1976:218-222. Publication ADM 76-338.
13. DeCaria CM, Hollander E, Grossman R, Wong CM, Mosovich SA, Cherkasky S. Diagnosis, neurobiology, and treatment of pathological gambling. J Clin Psychiatry. 1996;57:80-83.
14. Linden RO, Pope HG, Jonas JM. Pathological gambling and major affective disorders: preliminary findings. J Clin Psychiatry. 1986;47:201-203.
15. Hollander E. Obsessive-Compulsive Related Disorders. Washington, DC: American Psychiatric Press; 1993.
16. McElroy SL, Pope HG Jr, Keck PE Jr, Hudson JI, Phillips KA, Strakowski SM. Are impulse-control disorders related to bipolar disorders? Compr Psychiatry. 1996;37:229-240.
17. Haller R, Hinterhuber H. Treatment of pathological gambling with carbamazepine. Pharmacopsychiatry. 1994;27:129.
18. Pallanti S, Quercioli L, Sood E, Hollander E. Lithium and valproate treatment of pathological gambling: a randomized single-blind study. J. Clin Psychiatry. 2002;63:559-564.
19. Hollander E, Pallanti S, Allen A, Sood E, Baldini Rossi N. Does sustained-release lithium reduce impulsive gambling and affective instability versus placebo in pathological gamblers with bipolar spectrum disorders? Am J Psychiatry. 2005; 162:137-145.
20. Winters KC, Kushner MG. Treatment issues pertaining to pathological gamblers with a comorbid disorder. J Gambl Stud. 2003;19:261-267.